カテゴリー： 世界, 医療/バイオ, MarketsandMarkets

単一細胞解析のグローバル市場予測（～2028）：消耗品、装置

【英語タイトル】Single cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instrument), Technique (Flow Cytometry, NGS, Microscopy, MS), Application (Research, Medical), End User (Pharma, Biotech, Hospitals) - Global Forecast to 2028

MarketsandMarketsが出版した調査資料（BT4224-23）・商品コード：BT4224-23
・発行会社（調査会社）：MarketsandMarkets
・発行日：2023年6月30日
・ページ数：332
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

MarketsandMarkets社では、世界の単一細胞解析市場規模が2023年159億ドルから2028年71億ドルまで、予測期間中、年平均15.3%成長すると予測しています。当調査資料は、単一細胞解析の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（消耗品、装置）分析、細胞タイプ別（ヒト、動物、微生物）分析、手法別（フローサイトメトリー、NGS、ポリメラーゼ連鎖反応、顕微鏡検査、その他）分析、用途別（研究用、医療用）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、その他地域）分析、競争状況などの項目を掲載しています。なお、当書に掲載されている企業情報には、Becton、Dickinson and Company (US)、Danaher Corporation (US)、Merck KGaA (Germany)、QIAGEN N.V. (Netherlands)、Thermo Fisher Scientific, Inc. (US)、10x Genomics (US)Promega Corporation (US)、Illumina, Inc. (US)、Bio-Rad Laboratories (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の単一細胞解析市場規模：製品別
　 - 単一細胞解析消耗品の市場規模
　 - 単一細胞解析装置の市場規模
・世界の単一細胞解析市場規模：細胞タイプ別
　 - ヒト細胞の市場規模
　 - 動物細胞の市場規模
　 - 微生物細胞の市場規模
・世界の単一細胞解析市場規模：手法別
　 - フローサイトメトリー法の市場規模
　 - NGS法の市場規模
　 - ポリメラーゼ連鎖反応法の市場規模
　 - 顕微鏡検査法の市場規模
　 - その他手法の市場規模
・世界の単一細胞解析市場規模：用途別
　 - 研究用単一細胞解析の市場規模
　 - 医療用単一細胞解析の市場規模
・世界の単一細胞解析市場規模：地域別
　 - 北米の単一細胞解析市場規模
　 - ヨーロッパの単一細胞解析市場規模
　 - アジア太平洋の単一細胞解析市場規模
　 - 南米の単一細胞解析市場規模
　 - その他地域の単一細胞解析市場規模
・競争状況
・企業情報

“世界の単一細胞解析市場規模は2023年の35億米ドルから2028年には71億米ドルに達すると予測され、予測期間中の年平均成長率は15.3%”

マイクロフルイディクス、液滴ベース法、ハイスループットシーケンスプラットフォームなど、新しく先進的な単一細胞解析技術の開発が市場の成長を促進しています。さらに、個別化医療への注目の高まり、ライフサイエンスやバイオテクノロジー研究に対する政府や民間組織の投資が、単一細胞解析製品や技術の需要を促進しています。

“消耗品セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長すると予想”
製品別では、単一細胞解析市場は消耗品と機器に区分されます。消耗品セグメントは予測期間中に最も高いCAGRで成長すると予測されています。成長の背景には、細胞ベースの研究における消耗品の需要の増加があります。液滴ベース法やマイクロフルイディクスなどのハイスループット単一細胞解析技術では、効率的な細胞捕捉、バーコード化、処理にマイクロ流体チップ、試薬、ビーズなどの消耗品が必要です。これらの技術が普及し、研究者がより多くの単一細胞を同時に分析しようとするにつれて、消耗品に対する需要は増加します。サンプル調製は単一細胞解析において重要なステップであり、消耗品は細胞の分離、溶解、核酸の抽出において重要な役割を果たします。細胞分離試薬、抽出キット、反応チューブなどの消耗品は、効率的で信頼性の高い単一細胞の分離と調製に必要であり、消耗品セグメントの成長に貢献しています。あらかじめ最適化されたキット、プレート、チューブなどの消耗品は、実験ワークフローの合理化と標準化に役立ち、シングルセル解析の効率を改善し、ばらつきを低減します。研究者は、一貫性のある正確な結果を保証するために、シングルセルアプリケーション専用に設計された消耗品を好むことがよくあります。

“ヒト細胞セグメントが2023年に圧倒的シェアを占める見込み”
細胞タイプに基づき、市場はヒト細胞、動物細胞、微生物細胞に区分されます。ヒト細胞セグメントは、ヒト疾患研究への関心の高まりから、予測期間中に圧倒的なシェアを占めると予想されています。ヒトの組織や臓器内の細胞の不均一性を理解することは、様々な疾患の理解を進め、標的療法を開発する上で極めて重要です。単一細胞解析により、研究者はヒト組織内の個々の細胞間の遺伝的、エピジェネティック、表現型の違いを研究することができ、疾患メカニズムのより深い理解が可能になります。このため、ヒト細胞の単一細胞解析に対する需要が高まっています。

“次世代シーケンシングセグメントは、2023～2028年の予測期間中に最も高いCAGRで成長”
技術別に見ると、市場はフローサイトメトリー、次世代シーケンシング、ポリメラーゼ連鎖反応、顕微鏡、質量分析、その他の技術に区分されます。次世代シーケンシング分野は、予測期間中に最も高いCAGRで成長すると予測されています。この成長は、研究者が何千もの個々の細胞の遺伝物質を同時に解析できるハイスループットなシーケンス機能に起因しています。

“2022年、研究用途セグメントが圧倒的シェアを保持”
アプリケーションに基づき、単一細胞解析市場は研究アプリケーションと医療アプリケーションに区分されます。単一細胞解析市場で圧倒的なシェアを占めるのは研究用途分野です。単一細胞解析の研究用途には、がん研究、免疫学研究、神経学研究、幹細胞研究、組織再生、ウイルス学、創薬、老化研究などのその他研究用途が含まれます。単一細胞解析は、細胞機能と相互作用に関する前例のない洞察を提供することにより、基礎生物学研究に革命をもたらしました。これにより、研究者は新しい細胞タイプを発見し、希少な細胞集団を同定し、細胞系譜をマッピングすることができます。

“学術・研究機関セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長”
エンドユーザーに基づき、単一細胞解析市場は学術＆研究ラボ、バイオテクノロジー＆製薬会社、病院＆診断ラボ、細胞バンク＆IVFセンターに区分されます。アカデミック＆リサーチラボ部門は、予測期間中に最も高いCAGRで成長する見込みです。研究重視の傾向が強まっていることが、市場成長を予測する主な要因の1つです。

“アジア太平洋地域はより速いペースで成長”
単一細胞解析市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに分けられます。2022年には、北米が単一細胞解析市場で圧倒的なシェアを占めています。同地域の優位性は、同地域における支配的かつ主要な市場プレイヤーの存在、技術の進歩など様々な要因によるものです。アジア太平洋地域は、人口の増加や医療施設のインフラ整備のための政府の取り組みなど、さまざまな要因によって、より速いペースで成長する可能性があります。

本レポートのために実施した一次インタビューは以下のように分類されます：
– 回答者別 供給側80%、需要側20％
– 回答者の役職別（供給側） 管理職 – 35%、CXOおよび取締役 – 20%、経営幹部 – 45％
– 地域別 北米：25％、欧州：30％、アジア太平洋地域：30％、中南米：10％、中東・アフリカ：5％

レポート掲載企業リスト
• Becton, Dickinson and Company (US)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific, Inc. (US)
• 10x Genomics (US)
• Promega Corporation (US)
• Illumina, Inc. (US)
• Bio-Rad Laboratories (US)
• Standard BioTools (US)
• Agilent Technologies, Inc. (US)
• Tecan Group Ltd. (Switzerland)
• Sartorius AG (Germany)
• DiaSorin S.p.A. (Italy)
• Takara Bio, Inc. (Japan)
• Fluxion Biosciences (US)
• Menarini Silicon Biosystems Inc. (Italy)
• bioMérieux SA (France)
• Oxford Nanopore Technologies (UK)
• Cytek Biosciences (US)
• Corning Incorporated (US)
• Apogee Flow Systems Ltd. (UK)
• NanoCellect Biomedical (US)
• RareCyte, Inc. (US)
• On-chip Biotechnologies Co., Ltd. (Japan).

調査範囲
この調査レポートは、単一細胞解析市場の詳細な状況を掲載しています。製品、細胞タイプ、技術、用途、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの企業プロフィール、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、単一細胞解析市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競合状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置付け、適切な市場参入戦略を立てるのにも役立ちます。本レポートにより、関係者は市場動向を理解し、主要な市場促進要因、阻害要因、課題、動向、機会に関する情報を得ることができます。

本レポートは、以下のポイントに関する洞察を提供します：
– 単一細胞解析市場の成長に影響を与える主要な促進要因（単一細胞解析製品の技術的進歩、癌の有病率の上昇、製薬・バイオテクノロジー産業における研究開発の増加、幹細胞研究の成長、個別化医療への注目の高まり）、阻害要因（単一細胞解析製品の高コスト）、機会（単一細胞シーケンス（SCS）の高成長の可能性、単一細胞解析におけるマイクロフルイディクスの統合、アジアの新興市場）、課題（細胞療法開発のためのプロトコルとデータ統合および品質管理の標準化）分析。
– 製品開発／イノベーション： 新たに発売された製品に関する詳細な洞察、単一細胞解析市場の技術評価。
– 市場開発： 有利な市場に関する包括的な情報 – 当レポートでは、さまざまな地域の単一細胞解析市場を分析。
– 市場の多様化： 単一細胞解析市場における新製品、未開拓の地域、最近の開発、投資に関する詳細な情報。
– 競合評価： 単一細胞解析市場における主要企業の市場シェア、成長戦略、製品ラインアップを詳細に評価。また、利害関係者がシングルユースバイオリアクター市場の動向を理解するのにも役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS AND EXCLUSIONS 41
1.2.2 MARKETS COVERED 42
FIGURE 1 SINGLE-CELL ANALYSIS MARKET SEGMENTATION 42
1.2.3 YEARS CONSIDERED 43
1.3 CURRENCY 43
1.4 LIMITATIONS 43
1.5 STAKEHOLDERS 44
1.6 SUMMARY OF CHANGES 44
1.6.1 RECESSION IMPACT 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH APPROACH 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY RESEARCH 47
2.1.2 PRIMARY RESEARCH 47
FIGURE 3 SINGLE-CELL ANALYSIS MARKET: PRIMARY RESPONDENTS 48
2.2 MARKET ESTIMATION METHODOLOGY 48
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 49
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 49
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 50
FIGURE 6 INSIGHTS ON SINGLE-CELL ANALYSIS MARKET FROM PRIMARY EXPERTS 50
2.3 MARKET GROWTH RATE PROJECTIONS 51
FIGURE 7 MARKET GROWTH RATE PROJECTION, 2023–2028 52
FIGURE 8 SINGLE-CELL ANALYSIS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 52
2.4 DATA TRIANGULATION 53
FIGURE 9 DATA TRIANGULATION METHODOLOGY 53
2.5 RESEARCH ASSUMPTIONS 54
2.6 RISK ANALYSIS 54
2.7 RECESSION IMPACT 54
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 54
3 EXECUTIVE SUMMARY 56
FIGURE 10 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 56
FIGURE 11 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 12 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 13 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 58
FIGURE 14 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 59
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF SINGLE-CELL ANALYSIS MARKET 60
4 PREMIUM INSIGHTS 61
4.1 SINGLE-CELL ANALYSIS MARKET OVERVIEW 61
FIGURE 16 TECHNOLOGICAL ADVANCEMENTS IN SINGLE-CELL ANALYSIS PRODUCTS TO DRIVE MARKET 61
4.2 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SHARE, BY PRODUCT & COUNTRY (2022) 62
FIGURE 17 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SINGLE-CELL ANALYSIS MARKET IN 2022 62
4.3 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 62
FIGURE 18 CONSUMABLES WILL CONTINUE TO DOMINATE SINGLE-CELL ANALYSIS MARKET IN 2028 62
4.4 SINGLE-CELL ANALYSIS MARKET SHARE, BY END USER, 2023 VS. 2028 63
FIGURE 19 ACADEMIC & RESEARCH LABORATORIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2023 63
4.5 SINGLE-CELL ANALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES 63
FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN SINGLE-CELL ANALYSIS MARKET FROM 2023 TO 2028 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 21 SINGLE-CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
TABLE 2 SINGLE-CELL ANALYSIS MARKET: IMPACT ANALYSIS 65
5.2.1 DRIVERS 65
5.2.1.1 Technological advancements in single-cell analysis products 65
TABLE 3 RECENT TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES 65
5.2.1.2 Rising prevalence of cancer 66
TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2015 VS. 2018 VS. 2020 VS. 2035 67
5.2.1.3 Increasing R&D in pharmaceutical & biotechnology industries for complex diseases 68
FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014–2028 68
5.2.1.4 Growth in stem cell research 68
5.2.1.5 Growing focus on personalized medicine 69
5.2.2 RESTRAINTS 70
5.2.2.1 High cost of single-cell analysis products 70
5.2.3 OPPORTUNITIES 70
5.2.3.1 High growth potential of single-cell sequencing 70
5.2.3.2 Integration of microfluidics in single-cell analysis 71
5.2.3.3 Emerging Asian markets 71
5.2.4 CHALLENGES 71
5.2.4.1 Standardization of protocols and data integration & quality control for developing cell therapies 71
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72
FIGURE 23 REVENUE SHIFT AND NEW POCKETS FOR SINGLE-CELL ANALYSIS PROVIDERS 72
5.4 INDICATIVE PRICING ANALYSIS 72
TABLE 5 AVERAGE PRICE RANGE OF SINGLE-CELL ANALYSIS PRODUCTS (2022) 72
TABLE 6 AVERAGE SELLING PRICE OF NGS SYSTEMS (2022) 73
5.5 VALUE CHAIN ANALYSIS 73
FIGURE 24 MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 73
5.6 SUPPLY CHAIN ANALYSIS 74
FIGURE 25 SUPPLY CHAIN ANALYSIS OF SINGLE-CELL ANALYSIS MARKET 75
5.7 ECOSYSTEM ANALYSIS 75
FIGURE 26 ECOSYSTEM ANALYSIS: SINGLE-CELL ANALYSIS MARKET 75
TABLE 7 SINGLE-CELL ANALYSIS MARKET ECOSYSTEM 76
5.8 REGULATORY ANALYSIS 77
TABLE 8 REGULATORY SCENARIO 77
5.9 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 9 SINGLE-CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.9.1 THREAT OF NEW ENTRANTS 79
5.9.2 THREAT OF SUBSTITUTES 79
5.9.3 BARGAINING POWER OF BUYERS 80
5.9.4 BARGAINING POWER OF SUPPLIERS 80
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 80
5.10 KEY CONFERENCES & EVENTS IN 2023–2024 80
TABLE 10 SINGLE-CELL ANALYSIS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 80
5.11 TECHNOLOGY ANALYSIS 81
TABLE 11 COMPARISON OF SINGLE-CELL ANALYSIS TECHNOLOGIES 82
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 83
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-CELL ANALYSIS PRODUCTS 83
FIGURE 28 KEY BUYING CRITERIA FOR SINGLE-CELL ANALYSIS PRODUCTS 83
5.13 PATENT ANALYSIS 84
FIGURE 29 PATENTS GRANTED IN SINGLE-CELL ANALYSIS MARKET OVER LAST 10 YEARS 84
TABLE 12 INDICATIVE LIST OF PATENTS IN SINGLE-CELL ANALYSIS MARKET 85
6 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT 86
6.1 INTRODUCTION 87
TABLE 13 SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 87
6.2 CONSUMABLES 87
TABLE 14 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 88
TABLE 15 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 16 SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.2.1 BEADS 89
6.2.1.1 Wide application of beads in isolation of RNA and DNA to drive market 89
TABLE 17 SINGLE-CELL ANALYSIS BEADS MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 18 SINGLE-CELL ANALYSIS BEADS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
6.2.2 MICROPLATES 91
6.2.2.1 Increasing demand for genomic technologies to boost market 91
TABLE 19 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 20 SINGLE-CELL ANALYSIS MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.2.3 REAGENTS 92
6.2.3.1 Advancements in single-cell genomics to increase adoption of reagents 92
TABLE 21 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 22 SINGLE-CELL ANALYSIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.2.4 ASSAY KITS 94
TABLE 23 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 24 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 25 SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.2.4.1 Immunoassays 95
6.2.4.1.1 Innovations in immunoassays to drive growth 95
TABLE 26 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 27 SINGLE-CELL ANALYSIS IMMUNOASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
6.2.4.2 Cell-based assays 97
6.2.4.2.1 Rising R&D activities in pharma and biopharma companies to drive demand 97
TABLE 28 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 29 SINGLE-CELL ANALYSIS CELL-BASED ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
6.2.5 OTHER CONSUMABLES 98
TABLE 30 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 31 SINGLE-CELL ANALYSIS MARKET FOR OTHER CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 99
6.3 INSTRUMENTS 100
TABLE 32 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 33 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 34 SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.3.1 FLOW CYTOMETERS 102
6.3.1.1 Technological advancements in flow cytometry to drive market 102
TABLE 35 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 36 SINGLE-CELL ANALYSIS FLOW CYTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.3.2 NGS SYSTEMS 103
6.3.2.1 Advancements in NGS systems to support market growth 103
TABLE 37 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 38 SINGLE-CELL ANALYSIS NGS SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.3.3 PCR INSTRUMENTS 105
6.3.3.1 Use of PCR to amplify DNA and mRNA from single cells to study gene expression to boost market growth 105
TABLE 39 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 40 SINGLE-CELL ANALYSIS PCR INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.3.4 SPECTROPHOTOMETERS 106
6.3.4.1 Significant technological advancements to favor market growth 106
TABLE 41 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 42 SINGLE-CELL ANALYSIS SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.3.5 CELL COUNTERS 108
6.3.5.1 Reliable and quick results to support adoption 108
TABLE 43 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 44 SINGLE-CELL ANALYSIS CELL COUNTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
6.3.6 MICROSCOPES 109
6.3.6.1 Wide applications in cell-based research to drive adoption 109
TABLE 45 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 46 SINGLE-CELL ANALYSIS MICROSCOPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.3.7 HCS SYSTEMS 111
6.3.7.1 Increasing need for multi-parametric cell analysis to drive adoption 111
TABLE 47 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 48 SINGLE-CELL ANALYSIS HCS SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
6.3.8 MICROARRAYS 112
6.3.8.1 Increasing demand in molecular biology to support market growth 112
TABLE 49 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 50 SINGLE-CELL ANALYSIS MICROARRAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.3.9 OTHER INSTRUMENTS 114
TABLE 51 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 52 SINGLE-CELL ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 115
7 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE 116
7.1 INTRODUCTION 117
TABLE 53 SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 117
7.2 HUMAN CELLS 117
7.2.1 INCREASING CANCER RESEARCH & FUNDING TO PROPEL MARKET 117
TABLE 54 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY REGION, 2021–2028 (USD MILLION) 118
TABLE 55 SINGLE-CELL ANALYSIS MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 118
7.3 ANIMAL CELLS 119
7.3.1 INCREASING ANIMAL CELL RESEARCH TO DRIVE MARKET 119
TABLE 56 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 57 SINGLE-CELL ANALYSIS MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 120
7.4 MICROBIAL CELLS 120
7.4.1 RISING GOVERNMENT SUPPORT TO DETECT AND COMBAT ANTIMICROBIAL RESISTANCE TO PROPEL MARKET 120
TABLE 58 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 59 SINGLE-CELL ANALYSIS MARKET FOR MICROBIAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 122
8 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE 123
8.1 INTRODUCTION 124
TABLE 60 SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 124
8.2 FLOW CYTOMETRY 124
8.2.1 WIDE USAGE TO STUDY CELL MORPHOLOGIES AND IDENTIFY CANCEROUS CELLS TO DRIVE MARKET 124
TABLE 61 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 62 SINGLE-CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 125
8.3 NEXT-GENERATION SEQUENCING 126
8.3.1 ADVANTAGES SUCH AS EFFECTIVE SCREENING AND MANAGEMENT OF HIGH-VOLUME DATA TO BOOST ADOPTION 126
TABLE 63 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 64 SINGLE-CELL ANALYSIS MARKET FOR NEXT-GENERATION SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 127
8.4 POLYMERASE CHAIN REACTION 127
8.4.1 ADVANCEMENTS IN PCR TECHNIQUES TO SUPPORT MARKET GROWTH 127
TABLE 65 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 66 SINGLE-CELL ANALYSIS MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2021–2028 (USD MILLION) 128
8.5 MICROSCOPY 129
8.5.1 INCREASING INVESTMENTS IN CELL BIOLOGY RESEARCH TO PROPEL MARKET 129
TABLE 67 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 68 SINGLE-CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 130
8.6 MASS SPECTROMETRY 130
8.6.1 LAUNCH OF NEW AND ADVANCED PRODUCTS TO SUPPORT MARKET GROWTH 130
TABLE 69 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 70 SINGLE-CELL ANALYSIS MARKET FOR MASS SPECTROMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 131
8.7 OTHER TECHNIQUES 132
TABLE 71 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 72 SINGLE-CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2021–2028 (USD MILLION) 133
9 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION 134
9.1 INTRODUCTION 135
TABLE 73 SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
9.2 RESEARCH APPLICATIONS 135
TABLE 74 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 75 SINGLE CELL-ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 76 SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
9.2.1 CANCER RESEARCH 137
9.2.1.1 Growing prevalence of cancer to support market growth 137
TABLE 77 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 78 SINGLE-CELL ANALYSIS MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 138
9.2.2 IMMUNOLOGY RESEARCH 139
9.2.2.1 High incidence of infectious diseases and growing demand for advanced vaccines to propel market 139
TABLE 79 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 80 SINGLE-CELL ANALYSIS MARKET FOR IMMUNOLOGY RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 140
9.2.3 NEUROLOGY RESEARCH 140
9.2.3.1 Increasing incidence of neurological disorders to propel market 140
TABLE 81 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 82 SINGLE-CELL ANALYSIS MARKET FOR NEUROLOGY RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 142
9.2.4 STEM CELL RESEARCH 142
9.2.4.1 Rising investments in stem cell research to drive market 142
TABLE 83 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 84 SINGLE-CELL ANALYSIS MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 143
9.2.5 OTHER RESEARCH APPLICATIONS 144
TABLE 85 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 86 SINGLE-CELL ANALYSIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 145
9.3 MEDICAL APPLICATIONS 145
TABLE 87 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 88 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 89 SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 146
9.3.1 NONINVASIVE PRENATAL DIAGNOSIS 147
9.3.1.1 Rising prevalence of genetic diseases to drive market 147
TABLE 90 SINGLE-CELL ANALYSIS MARKET FOR NONINVASIVE PRENATAL DIAGNOSIS, BY REGION, 2021–2028 (USD MILLION) 147
TABLE 91 SINGLE-CELL ANALYSIS MARKET FOR NON INVASIVE PRENATAL DIAGNOSIS, BY COUNTRY, 2021–2028 (USD MILLION) 148
9.3.2 IN VITRO FERTILIZATION 148
9.3.2.1 Increasing demand for IVF procedures to support market growth 148
TABLE 92 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY REGION, 2021–2028 (USD MILLION) 149
TABLE 93 SINGLE-CELL ANALYSIS MARKET FOR IN VITRO FERTILIZATION, BY COUNTRY, 2021–2028 (USD MILLION) 149
9.3.3 CIRCULATING TUMOR CELL DETECTION 150
9.3.3.1 Rising prevalence of cancer to drive market 150
TABLE 94 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOR CELL DETECTION, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 95 SINGLE-CELL ANALYSIS MARKET FOR CIRCULATING TUMOUR CELL DETECTION, BY COUNTRY, 2021–2028 (USD MILLION) 151
10 SINGLE-CELL ANALYSIS MARKET, BY END USER 152
10.1 INTRODUCTION 153
TABLE 96 SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 153
10.2 ACADEMIC & RESEARCH LABORATORIES 153
10.2.1 INCREASING FUNDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET 153
TABLE 97 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 98 SINGLE-CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
10.3 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES 155
10.3.1 GROWTH IN DRUG DISCOVERY AND R&D ACTIVITIES TO SUPPORT MARKET GROWTH 155
TABLE 99 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 100 SINGLE-CELL ANALYSIS MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 156
10.4 HOSPITALS & DIAGNOSTIC LABORATORIES 157
10.4.1 HIGH PREVALENCE OF INFECTIOUS & CHRONIC DISEASES TO DRIVE ADOPTION 157
TABLE 101 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 158
TABLE 102 SINGLE-CELL ANALYSIS MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 158
10.5 CELL BANKS & IVF CENTERS 159
10.5.1 RISING DEMAND FOR PERSONALIZED & REGENERATIVE MEDICINE TO SUPPORT MARKET GROWTH 159
TABLE 103 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 104 SINGLE-CELL ANALYSIS MARKET FOR CELL BANKS & IVF CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 160
11 SINGLE-CELL ANALYSIS MARKET, BY REGION 161
11.1 INTRODUCTION 162
TABLE 105 SINGLE-CELL ANALYSIS MARKET, BY REGION, 2021–2028 (USD MILLION) 162
11.2 NORTH AMERICA 162
FIGURE 30 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET SNAPSHOT 163
TABLE 106 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 107 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 164
TABLE 108 NORTH AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 109 NORTH AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 110 NORTH AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 111 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 165
TABLE 112 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 166
TABLE 113 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 166
TABLE 114 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 115 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 116 NORTH AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 168
11.2.1 US 168
11.2.1.1 Increasing R&D investments and funding to drive market 168
FIGURE 31 NIH FUNDING FOR STEM CELL RESEARCH (2011–2021) 168
TABLE 117 US: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 169
TABLE 118 US: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 119 US: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 120 US: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 121 US: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 171
TABLE 122 US: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 171
TABLE 123 US: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 124 US: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 125 US: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 126 US: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 173
11.2.2 CANADA 173
11.2.2.1 High prevalence of hemophilia to drive market 173
TABLE 127 CANADA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 174
TABLE 128 CANADA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 129 CANADA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 130 CANADA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 131 CANADA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 175
TABLE 132 CANADA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 176
TABLE 133 CANADA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 134 CANADA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 135 CANADA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 136 CANADA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 178
11.2.3 NORTH AMERICA: RECESSION IMPACT 178
11.3 EUROPE 179
TABLE 137 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 138 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 179
TABLE 139 EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 140 EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 141 EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 142 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 181
TABLE 143 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 182
TABLE 144 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 145 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 146 EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 147 EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 184
11.3.1 GERMANY 184
11.3.1.1 Government support for research funding to propel market 184
TABLE 148 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 184
TABLE 149 GERMANY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 150 GERMANY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 151 GERMANY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 152 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 186
TABLE 153 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 187
TABLE 154 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 187
TABLE 155 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 156 GERMANY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 157 GERMANY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 189
11.3.2 UK 189
11.3.2.1 Favorable research conditions to support market growth 189
TABLE 158 UK: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 159 UK: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 160 UK: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 161 UK: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 162 UK: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 191
TABLE 163 UK: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 192
TABLE 164 UK: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 165 UK: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 166 UK: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 167 UK: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 194
11.3.3 FRANCE 194
11.3.3.1 High burden of cancer to propel market 194
TABLE 168 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 194
TABLE 169 FRANCE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 170 FRANCE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 171 FRANCE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 172 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 196
TABLE 173 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 197
TABLE 174 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197
TABLE 175 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 176 FRANCE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 177 FRANCE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 199
11.3.4 ITALY 199
11.3.4.1 Increasing cell biology seminars and conferences to drive market 199
TABLE 178 ITALY: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 200
TABLE 179 ITALY: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 180 ITALY: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 181 ITALY: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 182 ITALY: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 201
TABLE 183 ITALY: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 202
TABLE 184 ITALY: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 202
TABLE 185 ITALY: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 186 ITALY: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 187 ITALY: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 204
11.3.5 SPAIN 204
11.3.5.1 Strong R&D infrastructure and growing focus on cancer research to drive market 204
TABLE 188 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 205
TABLE 189 SPAIN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 190 SPAIN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 191 SPAIN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 192 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 206
TABLE 193 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 207
TABLE 194 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 207
TABLE 195 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 196 SPAIN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 208
TABLE 197 SPAIN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 209
11.3.6 REST OF EUROPE 209
TABLE 198 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 210
TABLE 199 REST OF EUROPE: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 200 REST OF EUROPE: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 201 REST OF EUROPE: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 202 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 211
TABLE 203 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 212
TABLE 204 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 212
TABLE 205 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 206 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 207 REST OF EUROPE: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 214
11.3.7 EUROPE: RECESSION IMPACT 214

11.4 ASIA PACIFIC 215
FIGURE 32 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET SNAPSHOT 215
TABLE 208 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 216
TABLE 209 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 216
TABLE 210 ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 211 ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 212 ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 213 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 218
TABLE 214 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 219
TABLE 215 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 216 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 217 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 218 ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 221
11.4.1 CHINA 221
11.4.1.1 Government initiatives to promote stem cell research to propel market 221
TABLE 219 CHINA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 221
TABLE 220 CHINA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 221 CHINA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 222 CHINA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 223 CHINA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 223
TABLE 224 CHINA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 224
TABLE 225 CHINA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 226 CHINA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 227 CHINA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 228 CHINA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 226
11.4.2 JAPAN 226
11.4.2.1 Rising geriatric population and growing focus on personalized medicine to drive market 226
TABLE 229 JAPAN: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025 226
TABLE 230 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 227
TABLE 231 JAPAN: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 232 JAPAN: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 233 JAPAN: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 234 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 229
TABLE 235 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 229
TABLE 236 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 229
TABLE 237 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 238 JAPAN: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 239 JAPAN: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 231
11.4.3 INDIA 231
11.4.3.1 Expansion of pharmaceutical and biotechnology industries to support market growth 231
TABLE 240 INDIA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 231
TABLE 241 INDIA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 242 INDIA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 243 INDIA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 244 INDIA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 233
TABLE 245 INDIA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 234
TABLE 246 INDIA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 234
TABLE 247 INDIA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 248 INDIA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 249 INDIA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 236
11.4.4 REST OF ASIA PACIFIC 236
TABLE 250 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 237
TABLE 251 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 252 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 253 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 254 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 238
TABLE 255 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 239
TABLE 256 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 239
TABLE 257 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 258 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 240
TABLE 259 REST OF ASIA PACIFIC: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 241
11.4.5 ASIA PACIFIC: RECESSION IMPACT 241
11.5 LATIN AMERICA 242
11.5.1 EXPANSION OF BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES TO DRIVE MARKET 242
11.5.2 LATIN AMERICA: RECESSION IMPACT 242
TABLE 260 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 242
TABLE 261 LATIN AMERICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 262 LATIN AMERICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 263 LATIN AMERICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 244
TABLE 264 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 244
TABLE 265 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 245
TABLE 266 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 245
TABLE 267 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 268 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 269 LATIN AMERICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 247
11.6 MIDDLE EAST & AFRICA 247
11.6.1 RISING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES TO DRIVE MARKET 247
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 248
TABLE 270 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 248
TABLE 271 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 272 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS ASSAY KITS MARKET, BY TYPE, 2021–2028 (USD MILLION) 249
TABLE 273 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 274 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 250
TABLE 275 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 251
TABLE 276 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 251
TABLE 277 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 278 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 279 MIDDLE EAST & AFRICA: SINGLE-CELL ANALYSIS MARKET, BY END USER, 2021–2028 (USD MILLION) 253
12 COMPETITIVE LANDSCAPE 254
12.1 INTRODUCTION 254
12.2 KEY STRATEGIES ADOPTED BY MARKET PLAYERS 254
FIGURE 33 SINGLE-CELL ANALYSIS MARKET: STRATEGIES ADOPTED 254
12.3 REVENUE ANALYSIS 255
FIGURE 34 REVENUE ANALYSIS FOR KEY COMPANIES, 2020–2022 255
12.4 MARKET SHARE ANALYSIS 255
FIGURE 35 SINGLE-CELL ANALYSIS MARKET SHARE, BY KEY PLAYER (2022) 256
TABLE 280 SINGLE-CELL ANALYSIS MARKET: DEGREE OF COMPETITION 256
12.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 257
12.5.1 STARS 257
12.5.2 EMERGING LEADERS 257
12.5.3 PERVASIVE PLAYERS 257
12.5.4 PARTICIPANTS 257
FIGURE 36 SINGLE-CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS, 2022 258
12.6 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 258
12.6.1 PROGRESSIVE COMPANIES 258
12.6.2 STARTING BLOCKS 258
12.6.3 RESPONSIVE COMPANIES 259
12.6.4 DYNAMIC COMPANIES 259
FIGURE 37 SINGLE-CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022 259
12.7 COMPETITIVE BENCHMARKING 260
12.7.1 COMPANY FOOTPRINT ANALYSIS (25 COMPANIES) 260
TABLE 281 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 260
12.7.2 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES) 261
TABLE 282 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET 261
12.7.3 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES (25 COMPANIES) 262
TABLE 283 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN SINGLE-CELL ANALYSIS MARKET 262
12.8 COMPETITIVE SCENARIO AND TRENDS 263
12.8.1 PRODUCT LAUNCHES 263
TABLE 284 SINGLE-CELL ANALYSIS MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023 263
12.8.2 DEALS 263
TABLE 285 SINGLE-CELL ANALYSIS MARKET: DEALS, JANUARY 2020–MAY 2023 264
12.8.3 EXPANSIONS 265
TABLE 286 SINGLE-CELL ANALYSIS MARKET: EXPANSIONS, JANUARY 2020–MAY 2023 265
13 COMPANY PROFILES 266
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
13.1 KEY COMPANIES 266
13.1.1 BECTON, DICKINSON AND COMPANY 266
TABLE 287 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 266
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 267
13.1.2 DANAHER CORPORATION 271
TABLE 288 DANAHER CORPORATION: COMPANY OVERVIEW 271
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 272
13.1.3 MERCK KGAA 276
TABLE 289 MERCK KGAA: COMPANY OVERVIEW 276
FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022) 277
13.1.4 THERMO FISHER SCIENTIFIC, INC. 281
TABLE 290 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 281
FIGURE 41 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 282
13.1.5 QIAGEN N.V. 286
TABLE 291 QIAGEN N.V.: COMPANY OVERVIEW 286
FIGURE 42 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 287
13.1.6 10X GENOMICS 289
TABLE 292 10X GENOMICS: COMPANY OVERVIEW 289
FIGURE 43 10X GENOMICS: COMPANY SNAPSHOT (2022) 290
13.1.7 ILLUMINA, INC. 293
TABLE 293 ILLUMINA, INC.: COMPANY OVERVIEW 293
FIGURE 44 ILLUMINA, INC.: COMPANY SNAPSHOT (2022) 294
13.1.8 BIO-RAD LABORATORIES 297
TABLE 294 BIO-RAD LABORATORIES: COMPANY OVERVIEW 297
FIGURE 45 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2022) 298
13.1.9 PROMEGA CORPORATION 302
TABLE 295 PROMEGA CORPORATION: COMPANY OVERVIEW 302
13.1.10 STANDARD BIOTOOLS 305
TABLE 296 STANDARD BIOTOOLS: COMPANY OVERVIEW 305
FIGURE 46 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022) 306
13.1.11 AGILENT TECHNOLOGIES, INC. 308
TABLE 297 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 308
FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 309
13.1.12 CORNING INCORPORATED 312
TABLE 298 CORNING INCORPORATED: COMPANY OVERVIEW 312
FIGURE 48 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 313
13.1.13 TAKARA BIO INC. 314
TABLE 299 TAKARA BIO INC.: COMPANY OVERVIEW 314
FIGURE 49 TAKARA BIO INC.: COMPANY SNAPSHOT (2022) 315
13.1.14 BIOMÉRIEUX SA 318
TABLE 300 BIOMÉRIEUX SA.: COMPANY OVERVIEW 318
FIGURE 50 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022) 319
13.1.15 TECAN GROUP LTD. 320
TABLE 301 TECAN GROUP LTD.: COMPANY OVERVIEW 320
FIGURE 51 TECAN GROUP LTD.: COMPANY SNAPSHOT (2022) 321
13.1.16 SARTORIUS AG 323
TABLE 302 SARTORIUS AG: COMPANY OVERVIEW 323
FIGURE 52 SARTORIUS AG: COMPANY SNAPSHOT (2022) 324
13.1.17 DIASORIN S.P.A. 326
TABLE 303 DIASORIN S.P.A.: COMPANY OVERVIEW 326
FIGURE 53 DIASORIN S.P.A.: COMPANY SNAPSHOT (2022) 327
13.2 OTHER PLAYERS 329
13.2.1 OXFORD NANOPORE TECHNOLOGIES PLC 329
13.2.2 CYTEK BIOSCIENCES 330
13.2.3 FLUXION BIOSCIENCES INC. 331
13.2.4 MENARINI SILICON BIOSYSTEMS 332
13.2.5 APOGEE FLOW SYSTEMS LTD. 333
13.2.6 NANOCELLECT BIOMEDICAL 334
13.2.7 ON-CHIP BIOTECHNOLOGIES CO., LTD. 335
13.2.8 RARECYTE, INC. 336
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
14 APPENDIX 337
14.1 DISCUSSION GUIDE 337
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 341
14.3 CUSTOMIZATION OPTIONS 343
14.4 RELATED REPORTS 343
14.5 AUTHOR DETAILS 344

★調査レポート[単一細胞解析のグローバル市場予測（～2028）：消耗品、装置] (コード：BT4224-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[単一細胞解析のグローバル市場予測（～2028）：消耗品、装置]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 細胞ベースアッセイのグローバル市場予測（～2028）：消耗品、装置＆ソフトウェア、サービス
  • 使い捨てアセンブリのグローバル市場予測（～2028）：バッグ、ろ過、ボトル、ミキシングアセンブリ
  • 世界の細胞培養市場（～2028）：製品別（消耗品（培地、血清、試薬）、容器（ローラーボトル、セルファクトリー）、装置（バイオリアクター、遠心分離機、インキュベーター））、用途別（mAbs、ワクチン、診断薬、ティッシュエンジニアリング）、エンドユーザー別
  • 世界のNGSサンプル調製市場（～2028）：製品別（試薬＆消耗品、ワークステーション）、ワークフロー別（ライブラリー前処理、ターゲットエンリッチメント）、サンプル種類別（DNA）、用途別（診断、創薬）、方法別（マイクロ流体、自動）、エンドユーザー別、地域別
  • In Vitro毒性試験の世界市場予測（～2028）：製品・サービス別、毒性エンドポイント別、技術別、手法別、産業別
  • 核酸分離・精製の世界市場予測（～2028）：製品別、手法別、種類別、用途別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆